Key Messages on HIV Counseling and Testing and the Use of ARVs

Flip Chart Resource

Download 2022KeyMessagesFlipChart (Flip Chart)

Ideas & Impact › Resources › Key Messages on HIV Counseling and Testing and the Use of ARVs

This tool was designed to assist health care worker during HIV testing and provide treatment adherence for those who are HIV positive as well as educating them how to take care of themselves; Viral load monitoring, TB prevention, Cervical cancer screening, and good nutrition.

Explore Related Resources

Search More Resources

Resource

Protecting Lives, Sustaining Progress

Published March 2026

The following landscape analysis of maternal and child health, HIV prevention, diagnosis, and treatment, and the historic strength of U.S. leadership in global aid provides an overview of these key areas of global health and recommendations for U.S. Congressional engagement and prioritization.

Topics:

Advocacy,

Children,

Global Health Security,

Health System Strengthening,

HIV,

Maternal and Child Health,

Mothers and Infants,

Women

Resource

Effectiveness of a Multi-component Facility-based Intervention on HIV-related Infant and Maternal Outcomes

Published April 2025

Introduction Even in the context of widespread access to prevention of vertical HIV transmission (PVT) services, health system challenges compromise health outcomes for women living with HIV and their children. The “Integrated Management Team to Improve Maternal-Child Outcomes” (IMPROVE) study measured the effect of a package of facility-based interventions on PVT and maternal and child […]

Countries:

Lesotho

February 2022, HEALTH CENTER OF MACIA, Locality Macia, District of Xai Xai, Gaza Province, Mozambique. Delivering a ARVs Bottle in a private pharmacy.

Journal Articles

HIV Drug Resistance Profile in Clients Experiencing Treatment Failure After the Transition to a Dolutegravir-Based First-Line Antiretroviral Treatment Regimen in Mozambique

Published January 2025

Real-world data on HIV drug resistance (HIVDR) after transitioning to tenofovir disoproxil fumarate/lamivudine/dolutegravir (TLD) are limited. We assessed HIVDR rates and patterns in clients with virological failure (VF) after switching from an NNRTI-based regimen to TLD. A cross-sectional study was conducted in Gaza, Mozambique (August 2021–February 2022), including adults on first-line ART for ≥12 months […]